Company

Amsterdam UMC, location VUmc

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 20, 2026 · INTERVENTIONAL STUDY

Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS

ClinicalTrials.gov

This is a trial registration with no results reported; the study is actively recruiting and designed to test whether an accelerated neuronavigated protocol achieves superior remission to standard rTMS in treatment-resistant depression, but outcome data are not yet available.

PreliminaryTreatment Resistant Depression NCT05900271 iTBS

Reported

Planned sample size108

Statistical power0.80

Significance level (alpha)0.05

AUG 18, 2026 · INTERVENTIONAL STUDY

A Clinical Imaging Study of the Changes in [18F]F-AraG Uptake Following Anti-PD-1 Therapy in Non-small Cell Lung Cancer

ClinicalTrials.gov

This is an active, unfinished registry record for a small exploratory imaging study with no results yet reported; it describes a planned diagnostic imaging biomarker investigation in early stages.

PreliminaryAdvanced Stage Non Small Cell Lung Cancer [18F]F-AraG PET scan Amsterdam UMC, location VUmc

Reported

Planned enrollment15

Primary outcome measure 1Relative change in [18F]F-AraG uptake in tu…

Primary outcome measure 2Correlation of baseline [18F]F-AraG uptake…